期刊文献+

高选择性环氧化酶-2抑制剂的进展与评价 被引量:6

Progress and Clinical Evualuation on Highly Selective Inhibitor of Cyclooxygenase-2(Xib)
下载PDF
导出
摘要 目的 :介绍高选择性环氧化酶 - 2抑制剂———昔布类药物进展 ,并评价其临床疗效 ,以供临床参考。方法 :查阅国内、外近期相关文献进行分析、评价。结果与结论 :昔布类高选择性环氧化酶 - 2抑制剂进展十分迅速 ,对环氧化酶 - 2的选择性高 ,在治疗骨关节炎和类风湿性关节炎、关节痛。 OBJECTIVE: To summarize the aspect of clinical application and progress on highly selective inhibitor of cyclooxygenase-2(Xib).METHODS:To collecte med ical literatures in recent years at home and abroad. RESULTS & CONCLUSION:Advanc e in highly selective inhibitor of cyclooxygenase-2(Xib) has been swiftly in rec ent years,with higher selectivity to COX-2 highly selective inhibitor of cycl ooxygenase-2 plays an important role in the treatment of osteoarthritis and rheu matoid arthritis,arthralgia,tumors and pain after operation.
出处 《中国医院用药评价与分析》 2003年第5期277-280,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 环氧化酶-2抑制剂 昔布类 药物 非甾体抗炎药 NSAID 抗炎镇痛作用 highly selective inhibition of COX-2 cyclooxygenase- 2 progress clinical application
  • 相关文献

参考文献7

二级参考文献18

  • 1吴军正,司徒镇强,刘斌,王为,陈建元.在抗癌药物敏感性试验中MTT法和MINI法的比较[J].实用口腔医学杂志,1994,10(1):55-56. 被引量:3
  • 2杨君义,宫玉珍.非甾体抗炎药对血小板功能的影响[J].国外医药(合成药.生化药.制剂分册),1996,17(3):160-163. 被引量:6
  • 3金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 4王贤才.临床用药大典[M].青岛:青岛出版社,1994.1512.
  • 5Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res, 1988; 48:4399~4404.
  • 6Harris RE, Namboodiri KK, Farrar WB. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology, 1996,7:203~205.
  • 7Harris RE, Kasbari S, Farrar WB. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep, 1999; 6:71~73.
  • 8Phillips RK, Wallace MH, Lynch PM, et al. A randomized, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut, 2002; 50:857~860.
  • 9Pentland AP, Schoggins JW, Scott GA, et al. Reduction of UVinduced skin tumors in hairless mice by selective COX-2 inhibition.Carcinogenesis, 1999; 20:1939~1944.
  • 10Grubbs C J, Lubet RA, Koki AT, et al. Celecoxib inhibits N-butyl-N(4-hydroxybutyl)- nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res, 2000;60:5599~5602.

共引文献95

同被引文献22

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部